Science & Tech

Indian Researchers Develop INR 100 Pill To Prevent Cancer Recurrence: Media

Researchers at India's premier cancer treatment facility, the Tata Institute in Mumbai, have announced a breakthrough treatment that can reduce the side effects of radiation and chemotherapy by 50% and prevent cancer recurrence.
Sputnik
Researchers have developed a promising solution for cancer recurrence: an INR 100 ($1.2) resveratrol+copper (R+Cu) tablet, which targets harmful cell-free chromatin particles (cfChPs) released by dying cancer cells.
Dr. Rajendra Badve, a senior cancer surgeon at Tata Memorial Hospital, shared with NDTV that this tablet holds immense potential to enhance cancer treatment, particularly for cancers of the pancreas, lungs, and oral cavity.
He explained that when cancer cells die, they break down into tiny fragments called chromatin particles. These particles can travel through the bloodstream, infiltrate healthy cells and trigger carcinogenesis.
In a decade-long effort, researchers and doctors at Tata Memorial Hospital developed pro-oxidant tablets that showed promise in erasing chromatin particles, significantly reducing the risk of cancer recurrence.
This cost-effective solution has the potential to transform cancer care worldwide, especially in resource-limited countries.
While doctors are optimistic about the tablet's effectiveness, human trials have yet to be conducted, highlighting the need for further research and evaluation.
Science & Tech
India's Indigenous Cancer Treatment 'CAR-T Cell Therapy' Cures Its First Patient
Discuss